KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biolife Solutions (BLFS) Acquisitions (2019 - 2021)

Biolife Solutions (BLFS) has disclosed Acquisitions for 3 consecutive years, with $1.5 million as the latest value for Q3 2021.

Quarterly Acquisitions rose 203.2% to $1.5 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2022, down 90.79% year-over-year, with the annual reading at $1.6 million for FY2021, 89.57% down from the prior year.
Acquisitions for Q3 2021 was $1.5 million at Biolife Solutions, down from $14.4 million in the prior quarter.
The five-year high for Acquisitions was $14.4 million in Q4 2020, with the low at -$12.4 million in Q3 2019.
Average Acquisitions over 3 years is $1.0 million, with a median of $1.0 million recorded in 2020.
The sharpest move saw Acquisitions surged 104.02% in 2020, then soared 203.2% in 2021.
Over 3 years, Acquisitions stood at -$12.4 million in 2019, then surged by 216.14% to $14.4 million in 2020, then tumbled by 89.51% to $1.5 million in 2021.
According to Business Quant data, Acquisitions over the past three periods came in at $1.5 million, $14.4 million, and $500000.0 for Q3 2021, Q4 2020, and Q3 2020 respectively.